T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
AtriCure
ATRC
$2.21B
| $77.6M | 0.01% |
2,214,691
-175,176
| -7% | -$5.55M |
|
752
Highwoods Properties
HIW
$3.51B
| $77.5M | 0.01% |
1,640,723
-65,052
| -4% | -$3.21M |
|
753
Constellium
CSTM
$3.98B
| $77.3M | 0.01% |
6,260,100
+45,022
| +0.7% | +$527K |
|
754
ICU Medical
ICUI
$4.56B
| $77M | 0.01% |
272,157
+19,013
| +8% | +$5.57M |
|
755
Globant
GLOB
$1.73B
| $76.8M | 0.01% |
1,302,452
+190,107
| +17% | +$11.1M |
|
756
Waste Management
WM
$89.8B
| $76.7M | 0.01% |
848,346
+67,111
| +9% | +$5.95M |
|
|
PRAH
757
DELISTED
PRA Health Sciences, Inc.
PRAH
| $76.5M | 0.01% |
694,374
+76,136
| +12% | +$7.93M |
|
|
CDR
758
DELISTED
Cedar Realty Trust, Inc
CDR
| $76.5M | 0.01% |
2,487,374
+7,066
| +0.3% | +$217K |
|
759
XPO
XPO
$25.1B
| $76.5M | 0.01% |
1,936,526
+33,893
| +2% | +$1.23M |
|
760
Colliers International
CIGI
$5.32B
| $76.5M | 0.01% |
985,880
-269,708
| -21% | -$21.5M |
|
761
Ingevity
NGVT
$2.6B
| $75.9M | 0.01% |
745,304
+48,668
| +7% | +$4.7M |
|
762
Truist Financial
TFC
$64.8B
| $75.9M | 0.01% |
1,562,703
-38,398
| -2% | -$1.97M |
|
763
CytomX Therapeutics
CTMX
$736M
| $75.6M | 0.01% |
4,087,603
+838,139
| +26% | +$19.1M |
|
764
General Motors
GM
$75.8B
| $75.5M | 0.01% |
2,242,765
-1,072,310
| -32% | -$39.5M |
|
765
Live Nation Entertainment
LYV
$43.3B
| $75M | 0.01% |
1,376,368
+123,669
| +10% | +$6.26M |
|
766
Coty
COTY
$2.42B
| $74.9M | 0.01% |
5,966,749
-202,400
| -3% | -$2.62M |
|
|
MNTV
767
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $74.9M | 0.01% |
+4,855,614
| New | +$79.9M |
|
|
CYBR
768
DELISTED
CyberArk
CYBR
| $74M | 0.01% |
926,389
-112,020
| -11% | -$7.87M |
|
769
Charles River Laboratories
CRL
$13.4B
| $73.7M | 0.01% |
547,440
+45,839
| +9% | +$5.66M |
|
|
ROIC
770
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $73.1M | 0.01% |
3,916,636
-1,086,542
| -22% | -$20.8M |
|
771
Atara Biotherapeutics
ATRA
$76.9M
| $73.1M | 0.01% |
70,674
+2,170
| +3% | +$2.12M |
|
772
WSFS Financial
WSFS
$4.16B
| $72.9M | 0.01% |
1,546,797
-107,411
| -6% | -$5.53M |
|
773
Preferred Bank
PFBC
$1.27B
| $72.6M | 0.01% |
1,241,663
-31,287
| -2% | -$1.96M |
|
|
CCMP
774
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $72.3M | 0.01% |
700,510
+28,401
| +4% | +$3.2M |
|
|
CIR
775
DELISTED
CIRCOR International, Inc
CIR
| $72M | 0.01% |
1,516,616
+46,712
| +3% | +$2.02M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.